Bendz H, Sjödin I, Aurell M
Department of Psychiatry, University Hospital, Lund, Sweden.
Nephrol Dial Transplant. 1996 Mar;11(3):457-60.
Controversy remains over the magnitude and reversibility of reduced renal function in long-term lithium patients.
Thirteen patients with 18 years (range 15-24) on lithium discontinued the treatment, and were re-examined twice after 5 and 9 weeks (4-16) off lithium. They were compared to a non-lithium psychiatric control group, matched for age and sex.
Glomerular filtration rate (GFR) tended to improve from 69 (39-96) to 74 (39-94) ml/min/1.73 m2 BSA, P = 0.057, which was not significantly different from 78 (61-106 ml/min per 1.73 m2 BSA in the controls. Reduced GFR was found in only two of the lithium patients off lithium, and in none of the controls. Maximal urinary concentrating capacity did not improve at all. It was 637 (130-875) mOsm/kg H2O in the lithium patients, which was lower than 856 (705-1.035) mOsm/kg H2O (P < 0.01) in the controls. Two of the lithium patients had isosthenuria.
Lithium patients often have an irreversible, clinically important reduction of Umax, sometimes progressing to nephrogenic diabetes insipidus, while GFR is well preserved in most patients.
长期服用锂盐的患者肾功能降低的程度及可逆性仍存在争议。
13例服用锂盐18年(范围15 - 24年)的患者停止治疗,在停用锂盐5周和9周(4 - 16周)后进行了两次复查。将他们与年龄和性别匹配的非锂盐治疗的精神科对照组进行比较。
肾小球滤过率(GFR)有从69(39 - 96)ml/min/1.73m²体表面积提高到74(39 - 94)ml/min/1.73m²体表面积的趋势,P = 0.057,与对照组的78(61 - 106)ml/min/1.73m²体表面积无显著差异。停用锂盐的锂盐治疗患者中仅2例出现GFR降低,而对照组无一例出现。最大尿浓缩能力完全没有改善。锂盐治疗患者的最大尿浓缩能力为637(130 - 875)mOsm/kg H₂O,低于对照组的856(705 - 1035)mOsm/kg H₂O(P < 0.01)。2例锂盐治疗患者出现等渗尿。
锂盐治疗患者常出现Umax不可逆的、具有临床意义的降低,有时会发展为肾性尿崩症,而大多数患者的GFR保持良好。